公开(公告)号：US20210061813A1

公开(公告)日：2021-03-04

申请号：US16440442

申请日：2019-06-13

Applicant: AbbVie Inc.

Inventor： Neil WISHART ,  Maria A. ARGIRIADI ,  David J. CALDERWOOD ,  Anna M. ERICSSON ,  Bryan A. FIAMENGO ,  Kristine E. FRANK ,  Michael M. FRIEDMAN ,  Dawn M. GEORGE ,  Eric R. GOEDKEN ,  Nathan S. JOSEPHSOHN ,  Biqin C. LI ,  Michael J. MORYTKO ,  Kent D. STEWART ,  Jeffrey W. VOSS ,  Grier A. WALLACE ,  Lu WANG ,  Kevin R. WOLLER

IPC: C07D487/14 ,  A61K45/06 ,  A61K31/4985 ,  A61K31/437 ,  C07D471/14 ,  C07D498/14 ,  C07D513/14

Abstract: The invention provides compounds of Formula (I) and Formula (II) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

公开(公告)号：US20230082167A1

公开(公告)日：2023-03-16

申请号：US17575731

申请日：2022-01-14

Applicant: AbbVie Inc.

Inventor： Neil WISHART ,  Maria A. ARGIRIADI ,  David J. CALDERWOOD ,  Anna M. Ericsson ,  Bryan A. FIAMENGO ,  Kristine E. FRANK ,  Michael M. FRIEDMAN ,  Dawn M. GEORGE ,  Eric R. GOEDKEN ,  Nathan S. JOSEPHSOHN ,  Biqin C. LI ,  Michael J. MORYTKO ,  Kent D. STEWART ,  Jeffrey W. VOSS ,  Grier A. WALLACE ,  Lu WANG ,  Kevin R. WOLLER

IPC: C07D487/14 ,  C07D498/14 ,  C07D513/14

Abstract: The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.